News >

Therapy Combinations May Become the Treatment of Choice in Ovarian Cancer

Wayne Kuznar
Published: Wednesday, Jul 12, 2017

Samir N. Khleif, MD

Samir N. Khleif, MD

The future of treatment for ovarian cancer may lie in immunotherapy combinations with PARP inhibitors or checkpoint inhibitors, said Samir N. Khleif, MD, during the 2017 ASCO Annual Meeting.1
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of ImmunotherapyAug 13, 20191.5
Publication Bottom Border
Border Publication
x